US Broker Ratings

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A 76% Upside Potential in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) has become a focal point for investors interested in the burgeoning healthcare sector, particularly in the niche of medical devices..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 9.93% Potential Upside Awaits Investors

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a prominent player in the healthcare sector, specializing in medical devices. With a market capitalization of $19.96 billion, the..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring the Investment Potential Amid Healthcare Sector Dynamics

Molina Healthcare Inc (MOH), a prominent player in the healthcare sector, is a company that offers managed healthcare services, focusing primarily on low-income families and individuals..

ResMed Inc. (RMD) Stock Analysis: Growth Potential in the Respiratory Health Sector with a 5.28% Upside

Investors looking for promising opportunities in the healthcare sector might find ResMed Inc. (NYSE: RMD) an intriguing contender. With a market capitalization of $40.66 billion, ResMed..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 22% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $10.92..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unveiling a 51.75% Potential Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, stands at an intriguing juncture in its journey of innovation and growth. With a..

Ionis Pharmaceuticals (IONS): Analyst Consensus and Growth Potential in the Booming Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is making waves with its innovative RNA-targeted medicines. With a market capitalization of $11.02..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating Its 4.32% Potential Upside Amidst Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) stands as an intriguing prospect for investors eyeing the biotechnology sector, particularly given its robust market presence and promising analyst ratings. Headquartered..

Eli Lilly and Company (LLY) Stock Analysis: Navigating the Healthcare Giant’s Growth and Valuation Potential

Eli Lilly and Company (NYSE: LLY) stands as a towering figure in the healthcare sector, boasting a formidable market capitalization of $752.91 billion. As a leader..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating a 13.92% Potential Upside in the Healthcare Sector

As one of the stalwarts in the healthcare industry, Merck & Company, Inc. (NYSE: MRK) remains an attractive proposition for investors with its robust pharmaceutical portfolio..

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising 138.98% Upside Potential in Biotechnology

Legend Biotech Corporation (NASDAQ: LEGN) is garnering attention from investors with its remarkable growth prospects in the biotechnology sector. With a market capitalization of $5.92 billion,..

Cencora, Inc. (COR) Stock Analysis: Exploring a 9.94% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a pivotal player in the healthcare distribution sector, presents an intriguing opportunity for investors. With a robust market capitalization of $58.7 billion,..

Globus Medical, Inc. (GMED) Stock Analysis: Unpacking a 32.77% Potential Upside

Globus Medical, Inc. (NYSE: GMED) is catching the eye of investors with a compelling potential upside of 32.77%, as suggested by analyst ratings. With a robust..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unpacking a 9% Potential Upside and Promising Growth Prospects

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing the attention of global investors with its innovative oncology treatments and promising growth..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with a Strong Revenue Growth and Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a leading biopharmaceutical innovator, continues to grab attention in the healthcare sector with its significant contributions to the biotechnology industry. With a..

Humana Inc. (HUM) Stock Analysis: Navigating Growth and Strategic Prospects in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the U.S. healthcare plans industry, continues to demonstrate robust business operations while navigating the complexities of the sector...

Elevance Health, Inc. (ELV) Stock Analysis: A Healthcare Giant with a 3.11% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, has been making significant strides in the sector with its comprehensive range of..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a Potential 37.82% Upside in Healthcare

For investors with an eye on the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents a compelling opportunity. As a leading provider of home and..

Gilead Sciences, Inc. (GILD) Stock Analysis: Assessing an 11.10% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations in the biopharmaceutical..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with Stable Revenue Growth and Modest Upside

Teleflex Incorporated (NYSE: TFX) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Wayne, Pennsylvania, Teleflex designs,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds